Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.61 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | CNR1 | P21554 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.52 |
| ▸ | GMNN | O75496 | 1/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | APEX1 | P27695 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1416577 | 1.00 | FAAH (0.61) | FAAHSOAT1CYP1A2CYP2C19MEN1 | |
| SCHEMBL1416574 | 1.00 | FAAH (0.61) | FAAHSOAT1CYP1A2CYP2C19MEN1 | |
| SCHEMBL1416618 | 1.00 | FAAH (0.61) | FAAHSOAT1CYP1A2CYP2C19MEN1 | |
| SCHEMBL1416542 | 1.00 | FAAH (0.61) | FAAHSOAT1CYP1A2CYP2C19MEN1 | |
| SCHEMBL1416621 | 1.00 | FAAH (0.61) | FAAHSOAT1CYP1A2CYP2C19MEN1 | |
| SCHEMBL1416544 | 1.00 | FAAH (0.61) | FAAHSOAT1CYP1A2CYP2C19MEN1 | |
| SCHEMBL4177621 | 1.00 | FAAH (0.61) | FAAHSOAT1CYP1A2CYP2C19MEN1 | |
| SCHEMBL11397133 | 0.96 | FAAH (0.56) | FAAHSOAT1CYP1A2CYP2C19MEN1 | |
| SCHEMBL11393684 | 0.96 | FAAH (0.56) | FAAHSOAT1CYP1A2CYP2C19MEN1 | |
| SCHEMBL1416741 | 0.95 | KDM4E (0.65) | FAAHSOAT1CYP1A2CYP2C19MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220204344-A1 | PROCESS FOR PREPARING CUBIC PI-PHASE MONOCHALCOGENIDES | B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (IL) | 2022-06-30 | — | — | US | claimed |
| EP-3939096-A1 | PROCESS FOR PREPARING CUBIC PI-PHASE MONOCHALCOGENIDES | B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University (IL) | 2022-01-19 | — | — | EP | claimed |
| WO-2020212981-A1 | PROCESS FOR PREPARING CUBIC PI-PHASE MONOCHALCOGENIDES | B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (IL) | 2020-10-22 | — | — | WO | claimed |
| CN-117417265-A | Lipid composition | 富士胶片株式会社 | 2024-01-19 | — | — | CN | disclosed |
| CN-112262122-B | Compound or salt and lipid particle thereof | 富士胶片株式会社 | 2023-10-13 | — | — | CN | disclosed |
| CN-116172975-A | Lipid particle, nucleic acid drug comprising same, and composition for nucleic acid delivery | 富士胶片株式会社 | 2023-05-30 | — | — | CN | disclosed |
| CN-114728016-A | Lipid composition | 富士胶片株式会社 | 2022-07-08 | — | — | CN | disclosed |
| US-20220204344-A1 | PROCESS FOR PREPARING CUBIC PI-PHASE MONOCHALCOGENIDES | B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (IL) | 2022-06-30 | — | — | US | disclosed |
| CN-113924128-A | Lipid composition | 富士胶片株式会社 | 2022-01-11 | — | — | CN | disclosed |
| CN-112262122-A | Compound or salt thereof, and lipid particle | 富士胶片株式会社 | 2021-01-22 | — | — | CN | disclosed |
| WO-2013016058-A1 | NOVEL BIS-NITROGEN CONTAINING CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY | MERCK SHARP & DOHME CORP. (US) | 2013-01-31 | — | — | WO | disclosed |
| US-6762175-B2 | LIPOPHILIC BIOLOGICALLY ACTIVE COMPOUND CONTAINING IN ITS MOLECULAR STRUCTURE ONE OR MORE FUNCTIONAL GROUPS SELECTED FROM ALCOHOL, ETHER, PHENYL, AMINO, AMIDO, THIOL, ACID AND ESTER IN WHICH ONE GROUP IS REPLACED BY LIPOPHILIC GROUP | NORSK HYDRO ASA (NO) | 2004-07-13 | — | — | US | disclosed |
| EP-0977725-B1 | NEW FATTY ACID DERIVATIVES | CONPHARMA AS (NO) | 2004-06-16 | — | — | EP | disclosed |
| US-20040063677-A1 | Methods of treating disorders using lipophilic derivatives | NORSK HYDRO ASA | 2004-04-01 | — | — | US | disclosed |
| US-20030153544-A1 | Lipophilic biologically active compound containing in its molecular structure one or more functional groups selected from alcohol, ether, phenyl, amino, amido, thiol, acid and ester in which one group is replaced by lipophilic group | CONPHARMA AS (NO) | 2003-08-14 | — | — | US | disclosed |
| US-20010006962-A1 | FATTY ACID DERIVATIVES | NORSK HYDRO ASA (NO) | 2001-07-05 | — | — | US | disclosed |
| CN-1067926-C | Solidifying method for forming and completely compacting powder material | HUANG XIAODI (CN) | 2001-07-04 | — | — | CN | disclosed |
| EP-0977725-A1 | NEW FATTY ACID DERIVATIVES | NORSK HYDRO ASA (NO) | 2000-02-09 | — | — | EP | disclosed |
| WO-1998032718-A1 | NEW FATTY ACID DERIVATIVES | NORSK HYDRO ASA (NO) | 1998-07-30 | — | — | WO | disclosed |
| CN-1154884-A | Solidifying method for forming and completely compacting powder material | HUANG XIAODI (CN) | 1997-07-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010006962-A1 | FATTY ACID DERIVATIVES | HADH, NR1H2, NR1H3 | FAAH 33/4885SOAT1 58/4885CYP1A2 207/4885 |
| US-20040063677-A1 | Methods of treating disorders using lipophilic derivatives | NCEH1, NR1H2, NR1H3 | FAAH 82/4885SOAT1 71/4885CYP1A2 425/4885 |
| US-20220204344-A1 | PROCESS FOR PREPARING CUBIC PI-PHASE MONOCHALCOGENIDES | KDR, HRH3, HRH4 | FAAH 3623/4885SOAT1 1440/4885CYP1A2 1762/4885 |
| US-20030153544-A1 | Lipophilic biologically active compound containing in its molecular structure one or more functional groups selected from alcohol, ether, phenyl, amino, amido, thiol, acid and ester in which one group is replaced by lipophilic group | TSPO, NR1H2, NR1H3 | FAAH 26/4885SOAT1 56/4885CYP1A2 343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.